Some US Senate Democrats have told the Department of Justice (DOJ) and the Federal Communications Commission (FCC) that they have serious concerns about the proposed T-Mobile-Sprint merger, reported The Hill. The Senators worry that the deal could hurt wireless consumers.
Senator Amy Klobuchar led a group of six Democrats along with Senator Bernie Sanders, in a letter to the DOJ’s Antitrust Division and the FCC, warning of the potential dangers of the US$26 billion deal.
“As more than three-quarters of American adults now own smartphones, including many who depend on these devices for their primary connection to the internet, an anticompetitive acquisition in the wireless market could result in higher prices for American consumers or force some people to forego their internet connection altogether,” the senators wrote.
The signatories to the letter were among the most outspoken critics of media consolidation in general, including Senators Elizabeth Warren and Ed Markey, both from Massachusetts, Senator. Amy Klobuchar (Democrat – Minnesota) and Bernie Sanders (the Vermont independent who caucuses with the Democrats).
They did not say they opposed the deal, but they spelled out the reasons they thought it needed close scrutiny.
Full Content: The Hill
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas